Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stack

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Medicinal Chemistry|September 20, 2002
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraineSandra A Filla, Mark A Winter, Kirk W Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2013
GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain modelsJose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, et al.
Journal of Medicinal Chemistry|June 25, 2005
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of painEsteban Dominguez, Smriti Iyengar, Harlan E Shannon, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacyJose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, et al.
Annals of the Rheumatic Diseases|July 26, 2023
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition diseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2023
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition DiseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Medicinal Chemistry|September 20, 2002
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraineSandra A Filla, Mark A Winter, Kirk W Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2013
GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain modelsJose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, et al.
Journal of Medicinal Chemistry|June 25, 2005
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of painEsteban Dominguez, Smriti Iyengar, Harlan E Shannon, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacyJose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, et al.
Annals of the Rheumatic Diseases|July 26, 2023
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition diseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2023
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition DiseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Pageof 7